Coagulopathies in horses.

The research article discusses the rarity of primary coagulopathies in horses, but acknowledges that coagulation and fibrinolysis changes often occur alongside inflammatory diseases. It also explains the importance of diagnosing these conditions accurately and treating any underlying ailments, whether they present coagulopathy symptoms or not.

Coagulopathies in horses

• The paper explores the occurrence of coagulopathies in horses, highlighting that primary coagulopathies, which are blood clotting disorders, are relatively rare in these animals.
• Instead, changes in the coagulation (process of blood clotting) and fibrinolysis (breakdown of clots) processes often occur alongside inflammatory diseases. This change in clotting can lead to abnormal hemostasis, or coagulation, which can contribute to either excessive bleeding (hemorrhage) or blood clot formations (thrombosis).

Understanding the pathophysiology

• According to the study, it becomes vital to understand the pathophysiology, i.e., how abnormal coagulation affects the function in a horse’s body.
• A clear comprehension of the pathophysiology of normal and abnormal hemostasis is necessary to correctly select and interpret diagnostic tests assessing coagulation and fibrinolysis essentials.

Treatment Procedures

• The study emphasizes the need to diagnose and treat the underlying disease causing the coagulation, regardless of whether clinical symptoms of coagulopathy are present or not.
• This underlying disease treatment happens because the coagulopathy could still pose threats if left untreated, even if it is not directly causing symptoms.
• Further, if there are clinical signs of coagulopathy, such as excessive bleeding or thrombosis, specific treatments may be initiated to handle these symptoms directly.